University Hosptial of North Norway
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Haugnes, Hege S
PEACE III, NCT02194842 / 2014-001787-36: Phase III Radium 223 mCRPC-

Active, not recruiting
3
446
Europe, Canada, RoW
Ra223, Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC, Bayer, Astellas Pharma Europe Ltd., UNICANCER, Canadian Urologic Oncology Group, Latin American Cooperative Oncology Group, Cancer Trials Ireland
Prostate Cancer
02/24
12/28
ProBio, NCT03903835 / 2018-002350-78: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Recruiting
3
750
Europe
Enzalutamide Oral Capsule, Xtandi, Abiraterone Oral Tablet, Zytiga, Carboplatin, Cabazitaxel 60 mg Solution for Injection, Docetaxel Injectable Solution, Radium Chloride Ra-223, Xofigo, Niraparib plus Abiraterone acetate plus Prednisone, Akeega, Capivasertib plus Docetaxel, Apalutamide, Erleada, Darolutamide, Nubeqa
Karolinska Institutet, The Swedish Research Council, Kom Op Tegen Kanker, Janssen Pharmaceutica N.V., Belgium, AstraZeneca, Cancerfonden
Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
12/26
12/26
GrandP/SPCG19, NCT05448547: Immediate Curative Vs Conservative Treatment in Older Men with M0, High-risk Prostate Cancer

Recruiting
3
980
Europe
Radiotherapy or surgery, initial observation, Hormone therapy
Sven Löffeler, Oslo University Hospital, Klinbeforsk
Prostate Cancer
12/29
12/36
NCT04298112: PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Completed
N/A
300
Europe
PSMA PET/CT, PSMA PET/MR
Norwegian University of Science and Technology, Haukeland University Hospital, University Hospital of North Norway, St Olavs Hospital University Hospital in Trondheim
Prostatic Neoplasms
05/23
05/23
NCT04790968: Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Completed
N/A
90
Europe
PSMA-PET, PSMA-PET/MRI, PSMA-PET/CT
Norwegian University of Science and Technology, St. Olavs Hospital, Haukeland University Hospital, University Hospital of North Norway
Prostatic Neoplasms, Neoplasm Metastasis
09/24
09/24
NCT04914026: MicroRNA as Markers in Testicular Cancer

Recruiting
N/A
350
Europe
Biomarker analysis
Haukeland University Hospital, Karolinska University Hospital, Sahlgrenska University Hospital, Sweden, Helse Fonna, University Hospital of North Norway, Oslo University Hospital
Testicular Germ Cell Cancer, Seminoma, Non-Seminoma Testicular Cancer, Stage I Testicular Cancer, Stage II Testicular Cancer, Stage III Testicular Cancer, Stage IV Testicular Cancer, Relapse Testicular Cancer
12/26
12/26

Download Options